
LA JOLLA, Calif., June 05, 2017 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company ...

Key Clinical Portfolio Development Progress Planned for 2018 Tedopi® (neoepitopes): Phase 3 clinical trial in ...
Click to continue to site. Closing